X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare with Piramal Healthcare - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs PIRAMAL ENTERPRISES - Comparison Results

PIRAMAL ENTERPRISES 
   Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES PIRAMAL ENTERPRISES ALKEM LABORATORIES/
PIRAMAL ENTERPRISES
 
P/E (TTM) x - 36.0 - View Chart
P/BV x 6.0 3.6 166.9% View Chart
Dividend Yield % 0.7 0.7 106.8%  

Financials

 ALKEM LABORATORIES   PIRAMAL ENTERPRISES
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
PIRAMAL ENTERPRISES
Mar-16
ALKEM LABORATORIES/
PIRAMAL ENTERPRISES
5-Yr Chart
Click to enlarge
High Rs1,5891,065 149.2%   
Low Rs1,232805 153.0%   
Sales per share (Unadj.) Rs417.5383.0 109.0%  
Earnings per share (Unadj.) Rs56.355.1 102.2%  
Cash flow per share (Unadj.) Rs64.774.1 87.4%  
Dividends per share (Unadj.) Rs12.7017.50 72.6%  
Dividend yield (eoy) %0.91.9 48.1%  
Book value per share (Unadj.) Rs292.9719.9 40.7%  
Shares outstanding (eoy) m119.57172.56 69.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.42.4 138.4%   
Avg P/E ratio x25.117.0 147.6%  
P/CF ratio (eoy) x21.812.6 172.7%  
Price / Book Value ratio x4.81.3 370.7%  
Dividend payout %22.631.8 71.0%   
Avg Mkt Cap Rs m168,653161,344 104.5%   
No. of employees `000NA3.8 0.0%   
Total wages/salary Rs m9,17116,898 54.3%   
Avg. sales/employee Rs ThNM17,472.6-  
Avg. wages/employee Rs ThNM4,466.9-  
Avg. net profit/employee Rs ThNM2,512.8-  
INCOME DATA
Net Sales Rs m49,91566,099 75.5%  
Other income Rs m1,6452,425 67.9%   
Total revenues Rs m51,56168,524 75.2%   
Gross profit Rs m8,48218,723 45.3%  
Depreciation Rs m1,0063,274 30.7%   
Interest Rs m6719,388 7.1%   
Profit before tax Rs m8,4518,485 99.6%   
Minority Interest Rs m-1143 -3,448.5%   
Prior Period Items Rs m01,593 0.0%   
Extraordinary Inc (Exp) Rs m0457 0.0%   
Tax Rs m1,6061,032 155.6%   
Profit after tax Rs m6,7319,506 70.8%  
Gross profit margin %17.028.3 60.0%  
Effective tax rate %19.012.2 156.3%   
Net profit margin %13.514.4 93.8%  
BALANCE SHEET DATA
Current assets Rs m27,06247,488 57.0%   
Current liabilities Rs m15,324104,362 14.7%   
Net working cap to sales %23.5-86.0 -27.3%  
Current ratio x1.80.5 388.1%  
Inventory Days Days6741 163.8%  
Debtors Days Days4151 80.7%  
Net fixed assets Rs m12,61026,532 47.5%   
Share capital Rs m239345 69.3%   
"Free" reserves Rs m34,490114,024 30.2%   
Net worth Rs m35,027124,221 28.2%   
Long term debt Rs m1,21275,812 1.6%   
Total assets Rs m54,387308,356 17.6%  
Interest coverage x13.61.9 714.5%   
Debt to equity ratio x00.6 5.7%  
Sales to assets ratio x0.90.2 428.2%   
Return on assets %13.66.1 222.1%  
Return on equity %19.27.7 251.1%  
Return on capital %24.910.0 249.5%  
Exports to sales %12.917.2 75.3%   
Imports to sales %3.16.6 46.7%   
Exports (fob) Rs m6,46111,362 56.9%   
Imports (cif) Rs m1,5404,364 35.3%   
Fx inflow Rs m6,56314,435 45.5%   
Fx outflow Rs m3,0125,183 58.1%   
Net fx Rs m3,5529,253 38.4%   
CASH FLOW
From Operations Rs m7,259-67,773 -10.7%  
From Investments Rs m1,864-8,768 -21.3%  
From Financial Activity Rs m-9,27376,199 -12.2%  
Net Cashflow Rs m-150-342 43.8%  

Share Holding

Indian Promoters % 66.9 52.9 126.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 33.1 4.0 827.5%  
FIIs % 0.0 26.6 -  
ADR/GDR % 0.0 0.0 -  
Free float % 0.0 16.5 -  
Shareholders   68,381 93,274 73.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   ABBOTT INDIA  JUBILANT LIFE SCIENCES  BIOCON LTD  IPCA LABS  NATCO PHARMA  

Compare ALKEM LABORATORIES With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Dr Reddy's & Lupin Surge over 2%(Closing)

Indian share markets continued to trade just above the dotted line in the afternoon session in a lackluster day of trading. At the closing bell, the BSE Sensex closed higher by 33 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Aug 22, 2017 (Close)

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES 5-YR ANALYSIS

COMPARE ALKEM LABORATORIES WITH

MARKET STATS